Masimo Corporation (0JZ2.L)
USD 172.78
(-1.63%)
USD 172.78
(-1.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 236.7 Million USD | -24.13% |
| 2022 | 355.2 Million USD | 11.13% |
| 2021 | 310.85 Million USD | 9.6% |
| 2020 | 293.77 Million USD | 16.13% |
| 2019 | 258.98 Million USD | 6.38% |
| 2018 | 229.59 Million USD | 5.79% |
| 2017 | 203.84 Million USD | 312.3% |
| 2016 | -102.41 Million USD | -205.89% |
| 2015 | 134.42 Million USD | 1.09% |
| 2014 | 106 Million USD | -10.72% |
| 2013 | 99.14 Million USD | 13.28% |
| 2012 | 94.59 Million USD | 0.8% |
| 2011 | 93.84 Million USD | -15.8% |
| 2010 | 114.15 Million USD | 26.11% |
| 2009 | 88.2 Million USD | 12.86% |
| 2008 | 78.88 Million USD | 8.07% |
| 2007 | 72.46 Million USD | 46.54% |
| 2006 | 49.44 Million USD | 156.13% |
| 2005 | 19.3 Million USD | -72.16% |
| 2004 | 69.35 Million USD | 1171.98% |
| 2003 | -6.47 Million USD | -7990.24% |
| 2002 | 74 Thousand USD | 0.0% |
| 1999 | -11.3 Million USD | -61.43% |
| 1998 | -7 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -59.6 Million USD | -11.69% |
| 2024 Q1 | 59.3 Million USD | -0.34% |
| 2024 Q2 | 52.2 Million USD | -11.97% |
| 2023 Q4 | 87.4 Million USD | 37.21% |
| 2023 Q3 | 63.7 Million USD | 16.88% |
| 2023 Q1 | 64.1 Million USD | -58.27% |
| 2023 Q2 | 54.5 Million USD | -14.98% |
| 2023 FY | - USD | -24.13% |
| 2022 Q4 | 153.6 Million USD | 180.29% |
| 2022 Q1 | 69.17 Million USD | -10.64% |
| 2022 Q2 | 22.1 Million USD | -68.05% |
| 2022 Q3 | 54.8 Million USD | 147.96% |
| 2022 FY | - USD | 11.13% |
| 2021 Q2 | 74.17 Million USD | 0.02% |
| 2021 Q1 | 74.15 Million USD | 14.27% |
| 2021 FY | - USD | 9.6% |
| 2021 Q3 | 76.98 Million USD | 3.79% |
| 2021 Q4 | 77.41 Million USD | 0.55% |
| 2020 FY | - USD | 16.13% |
| 2020 Q4 | 64.89 Million USD | -4.71% |
| 2020 Q3 | 68.1 Million USD | 9.37% |
| 2020 Q2 | 62.27 Million USD | -19.89% |
| 2020 Q1 | 77.73 Million USD | 26.28% |
| 2019 Q3 | 61.22 Million USD | -0.98% |
| 2019 FY | - USD | 6.38% |
| 2019 Q1 | 61.44 Million USD | 14.3% |
| 2019 Q2 | 61.82 Million USD | 0.63% |
| 2019 Q4 | 61.55 Million USD | 0.55% |
| 2018 Q3 | 53.8 Million USD | -5.88% |
| 2018 FY | - USD | 5.79% |
| 2018 Q1 | 59.12 Million USD | -0.33% |
| 2018 Q2 | 57.16 Million USD | -3.32% |
| 2018 Q4 | 53.75 Million USD | -0.09% |
| 2017 Q2 | 51.59 Million USD | 7.64% |
| 2017 Q4 | 59.32 Million USD | 12.15% |
| 2017 Q1 | 47.93 Million USD | 120.88% |
| 2017 FY | - USD | 312.3% |
| 2017 Q3 | 52.89 Million USD | 2.53% |
| 2016 FY | - USD | -205.89% |
| 2016 Q3 | 40.82 Million USD | 0.78% |
| 2016 Q1 | 41.38 Million USD | 1879.36% |
| 2016 Q2 | 40.51 Million USD | -2.12% |
| 2016 Q4 | -229.6 Million USD | -662.37% |
| 2015 FY | - USD | 1.09% |
| 2015 Q4 | -2.32 Million USD | -107.26% |
| 2015 Q3 | 32.04 Million USD | 15.1% |
| 2015 Q2 | 27.84 Million USD | -10.63% |
| 2015 Q1 | 31.15 Million USD | -13.42% |
| 2014 Q3 | 20.99 Million USD | -2.24% |
| 2014 Q1 | 17.21 Million USD | -45.58% |
| 2014 Q4 | 35.98 Million USD | 71.4% |
| 2014 FY | - USD | -10.72% |
| 2014 Q2 | 21.47 Million USD | 24.74% |
| 2013 Q4 | 31.63 Million USD | 34.04% |
| 2013 Q3 | 23.6 Million USD | -9.21% |
| 2013 Q2 | 25.99 Million USD | 0.28% |
| 2013 FY | - USD | 13.28% |
| 2013 Q1 | 25.92 Million USD | 3.15% |
| 2012 Q3 | 20.48 Million USD | -19.17% |
| 2012 FY | - USD | 0.8% |
| 2012 Q4 | 25.13 Million USD | 22.67% |
| 2012 Q1 | 24.67 Million USD | 10.8% |
| 2012 Q2 | 25.34 Million USD | 2.75% |
| 2011 Q1 | 27.23 Million USD | 17.09% |
| 2011 Q3 | 18.93 Million USD | -19.09% |
| 2011 Q4 | 22.26 Million USD | 17.6% |
| 2011 FY | - USD | -15.8% |
| 2011 Q2 | 23.4 Million USD | -14.09% |
| 2010 Q4 | 23.26 Million USD | 0.23% |
| 2010 FY | - USD | 26.11% |
| 2010 Q1 | 42.7 Million USD | 87.02% |
| 2010 Q3 | 23.21 Million USD | 4.2% |
| 2010 Q2 | 22.27 Million USD | -47.84% |
| 2009 Q1 | 21.63 Million USD | -2.17% |
| 2009 Q4 | 22.83 Million USD | 2.23% |
| 2009 Q3 | 22.33 Million USD | 3.55% |
| 2009 FY | - USD | 12.86% |
| 2009 Q2 | 21.57 Million USD | -0.31% |
| 2008 Q1 | 15.5 Million USD | -13.78% |
| 2008 Q4 | 22.12 Million USD | -1.48% |
| 2008 Q3 | 22.45 Million USD | 23.15% |
| 2008 Q2 | 18.23 Million USD | 17.57% |
| 2008 FY | - USD | 8.07% |
| 2007 Q3 | 18.17 Million USD | -8.37% |
| 2007 Q1 | 16.46 Million USD | -88.48% |
| 2007 Q2 | 19.83 Million USD | 20.5% |
| 2007 FY | - USD | 46.54% |
| 2007 Q4 | 17.98 Million USD | -1.03% |
| 2006 FY | - USD | 156.13% |
| 2006 Q2 | 58.34 Million USD | 18.33% |
| 2006 Q3 | 58.34 Million USD | 0.0% |
| 2006 Q4 | 142.94 Million USD | 145.0% |
| 2006 Q1 | 49.3 Million USD | 171.34% |
| 2005 Q1 | 26.97 Million USD | 0.0% |
| 2005 FY | - USD | -72.16% |
| 2005 Q2 | 26.97 Million USD | 0.0% |
| 2005 Q3 | 26.97 Million USD | 0.0% |
| 2005 Q4 | -69.11 Million USD | -356.23% |
| 2004 FY | - USD | 1171.98% |
| 2003 FY | - USD | -7990.24% |
| 2002 FY | - USD | 0.0% |
| 1999 Q3 | -2.3 Million USD | 0.0% |
| 1999 FY | - USD | -61.43% |
| 1999 Q4 | -3.5 Million USD | -52.17% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 329.929% |
| Accuray Incorporated | 9 Million USD | -2527.373% |
| Align Technology, Inc. | 799.03 Million USD | 70.377% |
| Elevance Health Inc. | 10.49 Billion USD | 97.744% |
| AxoGen, Inc. | -13.32 Million USD | 1875.96% |
| Boston Scientific Corporation | 3.61 Billion USD | 93.449% |
| CVS Health Corporation | 18.17 Billion USD | 98.698% |
| Cardinal Health, Inc. | 1.97 Billion USD | 88.033% |
| Centene Corporation | -463 Million USD | 151.123% |
| DaVita Inc. | 2.34 Billion USD | 89.912% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 98.139% |
| Hologic, Inc. | 1.29 Billion USD | 81.739% |
| Humana Inc. | -561 Million USD | 142.193% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 80.561% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 82.459% |
| McKesson Corporation | 4.66 Billion USD | 94.928% |
| Patterson Companies, Inc. | 374.75 Million USD | 36.839% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 86.334% |
| ResMed Inc. | 1.6 Billion USD | 85.209% |
| Henry Schein, Inc. | 943 Million USD | 74.899% |
| Teladoc Health, Inc. | 153.99 Million USD | -53.704% |
| Universal Health Services, Inc. | 1.74 Billion USD | 86.423% |
| Veeva Systems Inc. | 429.33 Million USD | 44.868% |
| Baxter International Inc. | 2.77 Billion USD | 91.473% |
| Becton, Dickinson and Company | 4.27 Billion USD | 94.463% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 90.113% |
| Danaher Corporation | 7.49 Billion USD | 96.844% |
| Stryker Corporation | 5.16 Billion USD | 95.413% |
| Medtronic plc | 9.05 Billion USD | 97.386% |